Shanghai No 1 Pharmacy Co (SHSE:600833) Cyclically Adjusted Revenue per Share: ¥7.97 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600833 Shanghai No 1 Pharmacy Co Ltd SHSE:600833
62 GF Score
Price ¥11.70
GF Value ¥12.77
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai No 1 Pharmacy Co Cyclically Adjusted Revenue per Share?

Shanghai No 1 Pharmacy Co SHSE:600833 -1.52% 62 Cyclically Adjusted Revenue per Share is ¥7.97 as of Mar. 2026. GuruFocus rates SHSE:600833 with a GF Score™ of 62/100 and a GF Value™ of ¥12.77 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shanghai No 1 Pharmacy Co's adjusted revenue per share for the three months ended in Mar. 2026 was ¥2.173. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥7.97 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai No 1 Pharmacy Co's average Cyclically Adjusted Revenue Growth Rate was 3.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shanghai No 1 Pharmacy Co was 11.70% per year. The lowest was 1.80% per year. And the median was 5.00% per year.

As of today (2026-08-14), Shanghai No 1 Pharmacy Co's current stock price is ¥11.70. Shanghai No 1 Pharmacy Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥7.97. Shanghai No 1 Pharmacy Co's Cyclically Adjusted PS Ratio of today is 1.47.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai No 1 Pharmacy Co was 3.67. The lowest was 1.15. And the median was 1.56.


Shanghai No 1 Pharmacy Co  (SHSE:600833) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai No 1 Pharmacy Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=11.70/7.97
=1.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai No 1 Pharmacy Co was 3.67. The lowest was 1.15. And the median was 1.56.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shanghai No 1 Pharmacy Co Cyclically Adjusted Revenue per Share Related Terms


Shanghai No 1 Pharmacy Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shanghai No 1 Pharmacy Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai No 1 Pharmacy Co Cyclically Adjusted Revenue per Share Chart

Shanghai No 1 Pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.90 7.47 7.57 7.67 7.94

Shanghai No 1 Pharmacy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.69 7.71 7.81 7.94 7.97

Shanghai No 1 Pharmacy Co Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Shanghai No 1 Pharmacy Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai No 1 Pharmacy Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai No 1 Pharmacy Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai No 1 Pharmacy Co's Cyclically Adjusted PS Ratio falls into.


SHSE:600833
62GF Score
Shanghai No 1 Pharmacy Co Ltd SHSE:600833
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai No 1 Pharmacy Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai No 1 Pharmacy Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.173/116.3033*116.3033
=2.173

Current CPI (Mar. 2026) = 116.3033.

Shanghai No 1 Pharmacy Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.671 101.400 1.917
201609 1.576 102.400 1.790
201612 1.756 102.600 1.991
201703 1.946 103.200 2.193
201706 1.727 103.100 1.948
201709 1.605 104.100 1.793
201712 1.542 104.500 1.716
201803 1.404 105.300 1.551
201806 1.244 104.900 1.379
201809 1.200 106.600 1.309
201812 1.386 106.500 1.514
201903 1.381 107.700 1.491
201906 1.386 107.700 1.497
201909 1.352 109.800 1.432
201912 1.501 111.200 1.570
202003 2.249 112.300 2.329
202006 1.596 110.400 1.681
202009 1.509 111.700 1.571
202012 1.824 111.500 1.903
202103 1.482 112.662 1.530
202106 1.349 111.769 1.404
202109 1.635 112.215 1.695
202112 1.752 113.108 1.801
202203 1.758 114.335 1.788
202206 2.490 114.558 2.528
202209 3.725 115.339 3.756
202212 3.846 115.116 3.886
202303 2.057 115.116 2.078
202306 1.968 114.558 1.998
202309 1.963 115.339 1.979
202312 2.163 114.781 2.192
202403 2.071 115.227 2.090
202406 1.933 114.781 1.959
202409 2.132 115.785 2.142
202412 2.436 114.893 2.466
202503 2.254 115.116 2.277
202506 2.215 114.907 2.242
202509 2.429 115.471 2.446
202512 2.697 115.832 2.708
202603 2.173 116.303 2.173

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥7.97 mean?
Shanghai No 1 Pharmacy Co (SHSE:600833) has a Cyclically Adjusted Revenue per Share of ¥7.97 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghai No 1 Pharmacy Co and its competitors.
Is Shanghai No 1 Pharmacy Co's Cyclically Adjusted Revenue per Share too high?
Shanghai No 1 Pharmacy Co's current Cyclically Adjusted Revenue per Share is ¥7.97. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's Cyclically Adjusted Revenue per Share compare to competitors?
Shanghai No 1 Pharmacy Co's Cyclically Adjusted Revenue per Share of ¥7.97 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghai No 1 Pharmacy Co and its competitors. Shanghai No 1 Pharmacy Co's current Cyclically Adjusted Revenue per Share is ¥7.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Fairly Valued. The stock's GF Value™ is ¥12.77, compared to a current price of ¥11.70 — trading 8.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥7.97. Shanghai No 1 Pharmacy Co's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current Cyclically Adjusted Revenue per Share is ¥7.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued. The current stock price of ¥11.70 is trading 8.4% below its estimated GF Value™ of ¥12.77. GuruFocus considers Shanghai No 1 Pharmacy Co to be Fairly Valued.

Key valuation signals for SHSE:600833:

  • Cyclically Adjusted Revenue per Share: ¥7.97
  • GF Value™: ¥12.77 vs. price of ¥11.70 (8.4% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai No 1 Pharmacy Co Business Description

Address No. 616 Nanjing East Road, Huangpu District, Shanghai, CHN, 200032
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
62GF Score

Get the complete analysis for SHSE:600833

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.70
Price
¥12.77
GF Value